Rohin Mhatre

Director, Repligen.

Companies

Parabilis Medicines, Inc.Officer Jun 9, 2026 to now¹
RepligenBoard member Mar 3, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Repligen RGEN5,014 shares³$882.7K at $176.05May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 14, 2026Granted 995 shares of Repligen³
May 15, 2025Granted 973 shares of Repligen⁴
May 16, 2024Granted 701 shares of Repligen⁵
May 18, 2023Granted 686 shares of Repligen⁶
May 26, 2022Granted 1,202 shares of Repligen⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARParabilis Medicines, Inc., Officer
2
SEC EDGARRepligen, Board member
3
SEC EDGARRepligen shares after the filing of May 14, 2026
4
SEC EDGARForm 4 filed May 19, 2025
5
SEC EDGARForm 4 filed May 20, 2024
6
SEC EDGARForm 4 filed May 22, 2023
7
SEC EDGARForm 4 filed May 31, 2022